| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Spyre Therapeutics, Inc. | Chief Legal Officer and Corporate Secretary | Stock Option (Right to Buy) | 63K | Feb 1, 2024 | Direct | ||
| Provention Bio, Inc. | Chief Legal Officer | Option to Purchase Common Stock | 0 | Apr 27, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| SYRE | Spyre Therapeutics, Inc. | Feb 1, 2024 | 1 | $0 | 4 | Feb 2, 2024 | Chief Legal Officer and Corporate Secretary |
| AGLE | Aeglea BioTherapeutics, Inc. | Sep 1, 2023 | 1 | $0 | 4 | Sep 5, 2023 | Chief Legal Officer and Corporate Secretary |
| AGLE | Aeglea BioTherapeutics, Inc. | Sep 1, 2023 | 0 | $0 | 3 | Sep 5, 2023 | Chief Legal Officer and Corporate Secretary Exhibit 24 - Power of Attorney |
| PRVB | Provention Bio, Inc. | Apr 27, 2023 | 4 | $0 | 4 | Apr 27, 2023 | Chief Legal Officer |
| PRVB | Provention Bio, Inc. | Jan 10, 2023 | 1 | $0 | 4 | Jan 11, 2023 | Chief Legal Officer |
| PRVB | Provention Bio, Inc. | Nov 22, 2022 | 1 | $0 | 4 | Nov 23, 2022 | Chief Legal Officer |
| PRVB | Provention Bio, Inc. | Mar 22, 2022 | 1 | $0 | 4 | Mar 24, 2022 | Chief Legal Officer |
| PRVB | Provention Bio, Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | Chief Legal Officer |
| PRVB | Provention Bio, Inc. | Aug 3, 2021 | 1 | $0 | 4 | Aug 5, 2021 | Chief Legal Officer |
| PRVB | Provention Bio, Inc. | May 12, 2021 | 1 | $0 | 4 | May 14, 2021 | Chief Legal Officer |